Latest News about NVS
Recent news which mentions NVS
Novartis' Kisqali Combo Therapy Extends Survival By One Year In Breast Cancer Patients
September 20, 2021
Tickers
NVS
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2021
September 20, 2021
From Benzinga
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
September 19, 2021
From Benzinga
Novartis' Prostate Cancer Therapy Linked To Improved Quality Of Life
September 17, 2021
Tickers
NVS
From Benzinga
Zymeworks' Zanidatamab Aces Mid-Stage Esophageal Cancer Trial
September 16, 2021
From Benzinga
3 Top Chinese Stocks to Watch in September
September 15, 2021
From Motley Fool
CureVac Shares Fall After Cutting COVID-19 Vaccine Production Plans
September 14, 2021
From Benzinga
Why Regenxbio Stock Is Way Up Today
September 13, 2021
From Motley Fool
ADHD Drug Developer Cingulate Plans NASDAQ Debut
September 10, 2021
From Benzinga
3 Red-Hot Healthcare Stocks to Buy in September
September 09, 2021
From Motley Fool
3 International Stocks to Buy for Dividend Growth
September 08, 2021
From InvestorPlace
Why Did Wedbush Downgrade Xoma?
September 07, 2021
From Benzinga
Novartis Stops Iscalimab Trial In Kidney Transplant Patients
September 03, 2021
Tickers
NVS
From Benzinga
Novartis, NHS England Ink Access Deal For Cholesterol Drug Leqvio
September 01, 2021
Tickers
NVS
From Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
From Benzinga
UCB Gets EU Approval For Bimekizumab In Psoriasis
August 25, 2021
From Benzinga
From Benzinga
Novartis' STAMP Inhibitor Under FDA Review For Myeloid Leukemia
August 25, 2021
Tickers
NVS
From Benzinga
From Benzinga
Could Veeva Systems Stock Help You Retire a Millionaire?
August 21, 2021
From Motley Fool
From Benzinga
From MarketWatch
WHO-Led Study To Test Three Anti-Inflammatory Drugs For COVID-19
August 11, 2021
From Benzinga
Here Are the Winners of Cowen's Big Pharma R&D Showdown
August 07, 2021
From Motley Fool
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
August 03, 2021
From Benzinga
Tilray Stock Makes Profit, Crowd Goes Wild!
August 02, 2021
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.